Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors

NCT00815945 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Mesenchymal Tumor
Carcinosarcoma
Leiomyosarcoma

Interventions

DRUG: PegLiposomal Doxorubicin
DRUG: Carboplatin

Sponsor

AGO Study Group

Collaborators

[object Object]